Your browser doesn't support javascript.
loading
Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis.
Rodriguez, Alfredo E; Rodriguez-Granillo, Alfredo M; Ascarrunz, Sergio D; Peralta-Bazan, Francisco; Cho, Mi Y.
Affiliation
  • Rodriguez AE; Cardiac Unit Otamendi Hospital, Buenos Aires School of Medicine, Cardiovascular Research Center (CECI), Buenos Aires, Argentina.
  • Rodriguez-Granillo AM; Cardiac Unit Otamendi Hospital, Buenos Aires School of Medicine, Cardiovascular Research Center (CECI), Buenos Aires, Argentina.
  • Ascarrunz SD; Cardiac Unit Otamendi Hospital, Buenos Aires School of Medicine, Cardiovascular Research Center (CECI), Buenos Aires, Argentina.
  • Peralta-Bazan F; Cardiac Unit Otamendi Hospital, Buenos Aires School of Medicine, Cardiovascular Research Center (CECI), Buenos Aires, Argentina.
  • Cho MY; Cardiac Unit Otamendi Hospital, Buenos Aires School of Medicine, Cardiovascular Research Center (CECI), Buenos Aires, Argentina.
Curr Pharm Des ; 24(4): 465-477, 2018.
Article in En | MEDLINE | ID: mdl-29308737
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Registries / Acute Coronary Syndrome / Percutaneous Coronary Intervention / Prasugrel Hydrochloride / Clopidogrel / Ticagrelor Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Curr Pharm Des Journal subject: FARMACIA Year: 2018 Document type: Article Affiliation country: Argentina Country of publication: United Arab Emirates
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Registries / Acute Coronary Syndrome / Percutaneous Coronary Intervention / Prasugrel Hydrochloride / Clopidogrel / Ticagrelor Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Curr Pharm Des Journal subject: FARMACIA Year: 2018 Document type: Article Affiliation country: Argentina Country of publication: United Arab Emirates